Heart Disease Trial, Recruiting NCT06436053 Sponsor: Abbott Medical Devices Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06436053
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older and are willing to follow the study requirements
  • People who have a medical reason to receive a dual-chamber pacemaker or cardiac resynchronization therapy device, and are scheduled to have an Abbott pacing device implanted
  • People who have a documented heart electrical conduction problem called left bundle branch block (LBBB) or intraventricular conduction delay (IVCD) (confirm with trial site if unsure which applies)
  • People whose heart's electrical signal (QRS duration) measures 130 milliseconds or longer on a heart tracing (ECG)
  • People whose heart's natural electrical pathway between the upper and lower chambers is working, with a PR interval of 250 milliseconds or less on a heart tracing (ECG)

Who may not be able to join:

  • People whose resting heart rate is faster than 100 beats per minute
  • People who have a second- or third-degree heart block (a significant blockage in the heart's electrical signal between the upper and lower chambers)
  • People who have been diagnosed with persistent fast heart rhythms originating in the upper chambers, such as atrial tachycardia or atrial fibrillation
  • People who have had a heart attack, a heart ablation procedure, abnormal electrolyte levels, or any other condition in the last 90 days that the trial doctor believes would make changes to pacing device settings unsafe
  • People who are currently taking part in another clinical trial
  • People who are pregnant or breastfeeding
  • People who have other medical, physical, personal, or psychological conditions that, in the trial doctor's opinion, could affect their ability to participate fully or could affect the reliability of the trial results
  • People who do not have legal authority to make their own decisions (confirm with trial site)
  • People who are unable to read or write

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 408-702-8604

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Abbott Medical Devices
Registry
ClinicalTrials.gov
Start date
15 May 2024
Est. completion
15 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

QRS duration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov